4-99088587-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000671.4(ADH5):​c.12+102C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 1,286,434 control chromosomes in the GnomAD database, including 304,526 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.69 ( 36020 hom., cov: 31)
Exomes 𝑓: 0.68 ( 268506 hom. )

Consequence

ADH5
NM_000671.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.11

Publications

6 publications found
Variant links:
Genes affected
ADH5 (HGNC:253): (alcohol dehydrogenase 5 (class III), chi polypeptide) This gene encodes a member of the alcohol dehydrogenase family. Members of this family metabolize a wide variety of substrates, including ethanol, retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. The encoded protein forms a homodimer. It has virtually no activity for ethanol oxidation, but exhibits high activity for oxidation of long-chain primary alcohols and for oxidation of S-hydroxymethyl-glutathione, a spontaneous adduct between formaldehyde and glutathione. This enzyme is an important component of cellular metabolism for the elimination of formaldehyde, a potent irritant and sensitizing agent that causes lacrymation, rhinitis, pharyngitis, and contact dermatitis. The human genome contains several non-transcribed pseudogenes related to this gene. [provided by RefSeq, Oct 2008]
ADH5 Gene-Disease associations (from GenCC):
  • AMED syndrome, digenic
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADH5NM_000671.4 linkc.12+102C>G intron_variant Intron 1 of 8 ENST00000296412.14 NP_000662.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADH5ENST00000296412.14 linkc.12+102C>G intron_variant Intron 1 of 8 1 NM_000671.4 ENSP00000296412.8

Frequencies

GnomAD3 genomes
AF:
0.685
AC:
104030
AN:
151842
Hom.:
35998
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.673
Gnomad AMI
AF:
0.636
Gnomad AMR
AF:
0.720
Gnomad ASJ
AF:
0.655
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.849
Gnomad FIN
AF:
0.674
Gnomad MID
AF:
0.715
Gnomad NFE
AF:
0.654
Gnomad OTH
AF:
0.674
GnomAD4 exome
AF:
0.684
AC:
775549
AN:
1134486
Hom.:
268506
AF XY:
0.686
AC XY:
383747
AN XY:
559192
show subpopulations
African (AFR)
AF:
0.675
AC:
16353
AN:
24240
American (AMR)
AF:
0.765
AC:
18435
AN:
24104
Ashkenazi Jewish (ASJ)
AF:
0.655
AC:
11524
AN:
17600
East Asian (EAS)
AF:
0.998
AC:
31978
AN:
32030
South Asian (SAS)
AF:
0.836
AC:
44081
AN:
52760
European-Finnish (FIN)
AF:
0.661
AC:
30969
AN:
46848
Middle Eastern (MID)
AF:
0.714
AC:
3316
AN:
4644
European-Non Finnish (NFE)
AF:
0.662
AC:
586489
AN:
885774
Other (OTH)
AF:
0.697
AC:
32404
AN:
46486
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
11584
23168
34752
46336
57920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16138
32276
48414
64552
80690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.685
AC:
104092
AN:
151948
Hom.:
36020
Cov.:
31
AF XY:
0.694
AC XY:
51521
AN XY:
74236
show subpopulations
African (AFR)
AF:
0.672
AC:
27862
AN:
41436
American (AMR)
AF:
0.720
AC:
11006
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.655
AC:
2275
AN:
3472
East Asian (EAS)
AF:
0.998
AC:
5124
AN:
5136
South Asian (SAS)
AF:
0.849
AC:
4089
AN:
4814
European-Finnish (FIN)
AF:
0.674
AC:
7119
AN:
10560
Middle Eastern (MID)
AF:
0.718
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
0.654
AC:
44400
AN:
67924
Other (OTH)
AF:
0.677
AC:
1427
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1653
3306
4958
6611
8264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
824
1648
2472
3296
4120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.665
Hom.:
4244
Bravo
AF:
0.686
Asia WGS
AF:
0.891
AC:
3085
AN:
3464

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
2.5
DANN
Benign
0.60
PhyloP100
-1.1
PromoterAI
-0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=14/86
disease causing (long InDel)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1154401; hg19: chr4-100009738; API